港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物医药B类股

708.812

-7.154-1.00%

涨家数：6

跌家数：27

平家数：1

市盈率：- -

高：728.504

开：715.966

低：707.752

收：715.966

成交量：4,337.95万

成交额：16.21亿

市值：4,539.22亿

流通市值：4,029.16亿

数据加载中...

总览新闻资讯

巨亏4.37亿元，股价反飙20％：基石药业“断臂”后的豪赌

黄南州24项传统藏医药技艺列入非遗名录

海南海药拟减持中国抗体不超5%股份，可套现最高约1.20亿港元，公司去年减亏至最多4.3亿元

深圳商报·读创

突然杀回来了！创新药ETF大盘点！

那曲西部四县协同推进藏医药发展，申扎县藏医院创级升级

中国西藏新闻网

猪价探底背后：行业全链有望重塑

中国经营网

诺诚健华（688428）披露证券变动月报表，4月3日股价下跌1.9%

海南海药拟减持中国抗体股份数量不超过6800万股

深度观察｜从“烧钱”走向“赚钱”，2025年中国创新药上市公司收入突破1000亿元，我们离全球“领跑”还差多远?

每日经济新闻

海南海药拟减持中国抗体不超5%股份

医药赛道领涨，港股通创新药ETF易方达（159316）本周成交放量

药闻 | 英硅智能再落地重磅合作 AI制药行业较量从拼算法转向拼验证与数据

美康生物(300439.SZ)取得一项医疗器械注册证

上交所上市委：泰诺麦博首发获通过

每日经济新闻

本周A股市场涨跌榜：创新药板块逆势走强，津药药业6连板

奇正藏药：在研产品小儿热立清颗粒属于中药分类1类创新药

新华医疗(600587.SH)子公司经颅磁刺激仪获得二类医疗器械注册证

化学制药行业经营数据全景梳理：制剂与原料药分化显著，创新药企成核心亮点

医疗器械行业经营数据全景分析：细分赛道分化显著，研发与效率成竞争关键

创新药BD再创新高，中国医药创新迎来高光时刻

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1574/news?page=12"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":708.8124,"timestamp":1776395905041,"preClose":715.96594,"halted":0,"volume":43379480,"delay":0,"changeRate":-0.009991,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-7.153564,"latestTime":"04-17 11:18:26","open":715.96594,"high":728.5041,"low":707.7522,"amount":1620954135,"amplitude":0.028984,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1776398400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"pbRate":5.627353,"peRate":-94.073273,"turnoverRate":0.001582,"increases":7,"decrements":26,"flats":0,"marketCap":453922420672,"floatMarketCap":402915524688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":728.5041,"amplitude":0.028984,"preClose":715.96594,"low":707.7522,"pbRate":"5.627353","latestPrice":708.8124,"volume":43379480,"delay":0,"open":715.96594,"prevYearClose":556.26263,"prevWeekClose":666.249,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":666.249,"twentyDayClose":575.488,"sixtyDayClose":612.872,"secType":"PLATE","market":"HK","turnoverRate":0.001582,"peRate":-94.073273,"marketCap":453922420672,"floatMarketCap":402915524688,"timestamp":1776395905041,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":27,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:12,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625171546","title":"巨亏4.37亿元，股价反飙20％：基石药业“断臂”后的豪赌","url":"https://stock-news.laohu8.com/highlight/detail?id=2625171546","media":"华夏时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625171546?lang=zh_cn&edition=fundamental","pubTime":"2026-04-05 08:35","pubTimestamp":1775349300,"startTime":"0","endTime":"0","summary":"华夏时报记者郭怡琳于娜北京报道近日，基石药业发布2025年度财报，全年收入2.70亿元，同比下降33.8%；年内亏损扩大至4.37亿元，较上年同期的9120万元亏损增加3.46亿元，亏损同比扩大3.79倍。这是基石药业自2019年上市以来亏损额最高的一份年报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604053695649372.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604053695649372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625158176","title":"黄南州24项传统藏医药技艺列入非遗名录","url":"https://stock-news.laohu8.com/highlight/detail?id=2625158176","media":"青海日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625158176?lang=zh_cn&edition=fundamental","pubTime":"2026-04-05 00:39","pubTimestamp":1775320740,"startTime":"0","endTime":"0","summary":"据悉，此次列入非遗名录的项目涵盖传统藏医药剂炮制、藏医药储存和加工技术、藏药浴、藏式按摩等特色康养养生方法。这一成果是对黄南州中藏医药文化传承工作的充分肯定，也为守护民族文化基因、传承民族智慧结晶提供了有力保障。今年以来，黄南州严格落实中央及青海省委、省政府关于扶持中医药事业发展的各项部署。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-05/doc-inhtkett7713522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09939","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624618445","title":"海南海药拟减持中国抗体不超5%股份，可套现最高约1.20亿港元，公司去年减亏至最多4.3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624618445","media":"深圳商报·读创","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624618445?lang=zh_cn&edition=fundamental","pubTime":"2026-04-04 22:08","pubTimestamp":1775311698,"startTime":"0","endTime":"0","summary":"4月3日，海南海药（000566）发布公告，公司拟通过集中竞价交易及大宗交易的方式减持中国抗体（03681）股份数量不超过6800万股，不超过公司总股本的5%。中国抗体系公司参股企业，公司持有中国抗体15888.21万股股份，占其总股本的11.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604043695624954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0070","03681","BK1574","BK0239","BK0146","BK1161","000566","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624695134","title":"突然杀回来了！创新药ETF大盘点！","url":"https://stock-news.laohu8.com/highlight/detail?id=2624695134","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624695134?lang=zh_cn&edition=fundamental","pubTime":"2026-04-04 11:35","pubTimestamp":1775273728,"startTime":"0","endTime":"0","summary":"图解创新药主题ETF","market":"sh","thumbnail":"https://img3.gelonghui.com/a0989-a422cedf-f15d-459f-90fa-e7074c8daf48.jpg?guru_height=2241&guru_width=3280&guru_size=1441563","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a0989-a422cedf-f15d-459f-90fa-e7074c8daf48.jpg?guru_height=2241&guru_width=3280&guru_size=1441563"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4307632","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_fund_highlight","symbols":["LU1969619763.USD","LU1770034418.SGD","LU1719994722.HKD","BK1583","BK1588","LU0307460666.USD","LU0588546209.SGD","LU2328871848.SGD","BK1500","06978","LU1303224171.USD","BK1161","BK1574","LU1251922891.USD","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624986346","title":"那曲西部四县协同推进藏医药发展，申扎县藏医院创级升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624986346","media":"中国西藏新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624986346?lang=zh_cn&edition=fundamental","pubTime":"2026-04-04 08:46","pubTimestamp":1775263560,"startTime":"0","endTime":"0","summary":"2024年8月，申扎县藏医院成功创建二级乙等民族医院，率先在西部四县藏医院中完成创级工作。筛选四县专家库人才共18人，后备人才库共26人，在申扎县举办西部四县藏医技术骨干培训班、乡村藏医技术骨干培训班，累计培训藏医骨干和专技人员60余人次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-04/doc-inhthssm8316395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","09939","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624662148","title":"猪价探底背后：行业全链有望重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2624662148","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624662148?lang=zh_cn&edition=fundamental","pubTime":"2026-04-04 03:58","pubTimestamp":1775246320,"startTime":"0","endTime":"0","summary":"供需波动导致我国生猪价格持续下探，进而引发行业内外的广泛讨论。数据显示，截至3月底，全国外三元生猪均价在9.4元/公斤左右，同比降幅30%，比年初水平下降20%。多位行业人士告诉《中国经营报》记者，按全国平均水平，当前生猪养殖完全成本仍在13元/公斤左右，按出栏体重125公斤推算，意味着头均亏损450元左右。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604043695328679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0070","BK1161","002714","BK0240","BK0183","BK0187","BK0195","BK0056","BK0028","BK0238","BK0197","BK0012","002567","000876","02137","LU1655091616.SGD","BK0039","300498","02714","002458","BK1237","BK0194","BK0077","002124","BK1574","BK0188","BK0201","BK0196","BK1587"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2624566806","title":"诺诚健华（688428）披露证券变动月报表，4月3日股价下跌1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624566806","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624566806?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 22:12","pubTimestamp":1775225533,"startTime":"0","endTime":"0","summary":"近日，诺诚健华发布港股公告《证券变动月报表》。公告显示，截至2026年3月31日，公司法定注册资本无变动，已发行股份总数与上月底结存一致，无增减。此外，2023年及2024年人民币股股权激励计划项下部分限制性股票失效，但本月未因协议安排导致股份增减。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32125629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK0239","09969","161027","688428","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624016650","title":"海南海药拟减持中国抗体股份数量不超过6800万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624016650","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624016650?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 21:14","pubTimestamp":1775222054,"startTime":"0","endTime":"0","summary":"北京商报讯（记者丁宁）4月3日晚间，海南海药（000566）发布公告称，公司拟通过集中竞价交易及大宗交易的方式减持公司目前持有的中国抗体制药有限公司（HK03681，以下简称“中国抗体”）股份数量不超过6800万股（占其总股本的比例不超过5%）。公告显示，中国抗体系公司参股企业，海南海药持有中国抗体15888.21万股股份，占其总股本的11.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604033695195266.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695195266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","000566","BK1574","BK0188","BK0070","BK0060","03681","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624502586","title":"深度观察｜从“烧钱”走向“赚钱”，2025年中国创新药上市公司收入突破1000亿元，我们离全球“领跑”还差多远?","url":"https://stock-news.laohu8.com/highlight/detail?id=2624502586","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624502586?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 21:06","pubTimestamp":1775221600,"startTime":"0","endTime":"0","summary":"随着2025年各家上市公司年报密集出炉，中国创新药产业的结构性变革，正式浮出水面。《每日经济新闻》记者不完全统计，百济神州、信达生物、华领医药、诺诚健华、乐普生物、荣昌生物、迈博药业、北海康成等公司扭亏为盈。创新药企终于从“烧钱”走向“赚钱”，与此同时，中国已跃升为全球创新药优质在研管线的核心供给地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604033695191747.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695191747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","06978","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624500126","title":"海南海药拟减持中国抗体不超5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2624500126","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624500126?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 20:57","pubTimestamp":1775221020,"startTime":"0","endTime":"0","summary":"4月3日，海南海药（000566）发布公告，公司拟通过集中竞价交易及大宗交易的方式减持中国抗体（03681）股份数量不超过6800万股，不超过公司总股本的5%。截至公告披露日前一交易日，公司持有中国抗体1.59亿股股票资产的市值约为2.8亿港元，此次交易旨在优化公司资产结构，提高资产流动性及使用效率。2025年前三季度，海南海药实现收入6.40亿元，归母净利润-2.42亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695191451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK1574","BK0070","BK0060","000566","BK1161","03681","BK0146","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624573726","title":"医药赛道领涨，港股通创新药ETF易方达（159316）本周成交放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2624573726","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624573726?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 19:53","pubTimestamp":1775217203,"startTime":"0","endTime":"0","summary":"本周，医药赛道领涨，指数层面，恒生港股通创新药指数上涨9.6%，中证港股通医药卫生综合指数上涨7.5%，中证创新药产业指数上涨4.2%，中证生物科技主题指数上涨2.5%，沪深300医药卫生指数上涨1.2%，港股通创新药ETF易方达(159316，联接基金A/C：024328/024329)本周成交额超50亿元，较上周大幅放量。国信证券指出，政府工作报告首次将生物医药定位为新兴支柱产业，并明确 “十五五” 期间将实施产业创新工程，推动生物医药成为新质生产力的重要引擎。同时，创新药出海合作持续深化，中国创新药研发能力获跨国药企认可，BD交易爆发式增长，商业化前景持续向好。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/03/20260403715725.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/03/20260403715725.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32125422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["09939","BK1574","159316","BK1515","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624512846","title":"药闻 | 英硅智能再落地重磅合作  AI制药行业较量从拼算法转向拼验证与数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2624512846","media":"新华财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624512846?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 18:10","pubTimestamp":1775211002,"startTime":"0","endTime":"0","summary":"新华财经上海4月3日电（记者杜康）继去年底登陆港交所以来，英硅智能在对外授权和跨国药企合作上动作频频。日前，这家由生成式人工智能驱动的生物医药科技公司宣布，与礼来达成总价值最高可达约27.5亿美元的药物发现合作，将利用其AI引擎加速多个治疗领域新型疗法的发现与开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695067135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","CHAT","AIPO","AGIX","BK1574","ARTY","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624659374","title":"美康生物(300439.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2624659374","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624659374?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 17:32","pubTimestamp":1775208736,"startTime":"0","endTime":"0","summary":"智通财经APP讯，美康生物(300439.SZ)公告，公司近日取得了由国家药品监督管理局颁发的医疗器械注册证，产品名称为：葡萄糖-6-磷酸脱氢酶测定试剂盒(葡萄糖-6-磷酸底物法)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0239","159883","BK1100","BK1574","300439","09996","BK1583","09997","BK0042","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624455659","title":"上交所上市委：泰诺麦博首发获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2624455659","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624455659?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 17:24","pubTimestamp":1775208240,"startTime":"0","endTime":"0","summary":"每经AI快讯，上交所上市委公告，珠海泰诺麦博制药股份有限公司（简称“泰诺麦博”）首发获通过。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-03/doc-inhtfkwx3717535.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-03/doc-inhtfkwx3717535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1861220033.SGD","LU2087625088.SGD","IE00BZ9MQY76.HKD","LU1852331112.SGD","BK4551","BK4585","LU2250418816.HKD","AIPO","BK4543","LU1861215975.USD","BK4587","AI","IE00B894F039.SGD","BK4588","AGIX","AIYY","LU2063271972.USD","LU2360106780.USD","ARTY","CHAT","LU0056508442.USD","BK4528","BK4608","LU0097036916.USD","SINA","BK4613","LU0353189680.USD","LU2360107168.USD","BK1191","BK4023","LU0353189763.USD","APPX","APP","BK4539","BK1574","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU2290526834.HKD","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624465613","title":"本周A股市场涨跌榜：创新药板块逆势走强，津药药业6连板","url":"https://stock-news.laohu8.com/highlight/detail?id=2624465613","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624465613?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 17:00","pubTimestamp":1775206801,"startTime":"0","endTime":"0","summary":"截至周五收盘，上证指数累计下跌0.86%，深证成指累计下跌2.96%，创业板指累计下跌4.44%。成交金额方面，本周沪深两市日均成交额达到18841亿元，较上周量能进一步萎缩。指数全景指数层面，本周A股主要指数延续调整态势。个股点睛个股方面，本周个股涨幅榜前五位分别是星辉环材、海泰新光、津药药业、宏昌科技、双鹭药业，累计涨幅分别为90.07%、75.26%、60.97%、43.45%、35.85%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/03/20260403487549.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/03/20260403487549.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260403/32124768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["06978","159992","399300","BK0012","BK1574","BK0102","600488","BK1161","BK0028","BK0239","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624580656","title":"奇正藏药：在研产品小儿热立清颗粒属于中药分类1类创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2624580656","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624580656?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 16:54","pubTimestamp":1775206447,"startTime":"0","endTime":"0","summary":"证券之星消息，奇正藏药(002287)04月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的产品中有创新药吗？奇正藏药回复：您好，公司在研产品小儿热立清颗粒属于中药分类1类创新药，在研产品正乳贴为原中药第6类新药，谢谢。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260403/32124767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002287","BK0188","BK0239","BK0028","BK1161","BK1574","06978","BK0033","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624653175","title":"新华医疗(600587.SH)子公司经颅磁刺激仪获得二类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2624653175","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624653175?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 15:43","pubTimestamp":1775202204,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华医疗(600587.SH)发布公告，公司子公司新华医疗康复产业(西安)有限公司于近日收到陕西省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，产品名称：经颅磁刺激仪。经颅磁刺激仪产品注册证的批准上市，有助于丰富和完善公司康复产品的产品线，为客户提供多种选择，有利于提升公司的核心竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK0028","BK0188","BK0251","BK1574","600587","BK1222","BK1100","BK1583","159883","09997"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624658144","title":"化学制药行业经营数据全景梳理：制剂与原料药分化显著，创新药企成核心亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=2624658144","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624658144?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 15:15","pubTimestamp":1775200500,"startTime":"0","endTime":"0","summary":"　　近日，各上市公司陆续披露2025年年度财务报告。截至4月1日，已有24家化学制药上市公司披露年报数据，本文通过对诺诚健华、恒瑞医药、丽珠集团等已披露数据企业2024-2025年全维度经营数据的深度拆解，从企业规模、研发投入、盈利能力、运营效率、人才激励五大核心维度，全面梳理行业发展格局，定位各企业指标头部与垫底阵营，为产业发展与投资研判提供数据支撑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-04-03/doc-inhtfeqz3741689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1191","01477","159992","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624658178","title":"医疗器械行业经营数据全景分析：细分赛道分化显著，研发与效率成竞争关键","url":"https://stock-news.laohu8.com/highlight/detail?id=2624658178","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624658178?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 15:14","pubTimestamp":1775200440,"startTime":"0","endTime":"0","summary":"　　近日，各上市公司陆续披露2025年年度财务报告。截至4月1日，已有17家医疗器械上市公司披露年报数据，本文通过对惠泰医疗、昊海生科、万东医疗等已披露数据企业2024-2025年全维度经营数据的深度拆解，从企业规模、研发投入、盈利能力、运营效率、人才激励五大核心维度，全面梳理行业发展格局，定位各企业指标头部与垫底阵营，为产业发展与投资研判提供数据支撑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-04-03/doc-inhtfeqw0294193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1222","159883","BK1100","09997","BK1583","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624630473","title":"创新药BD再创新高，中国医药创新迎来高光时刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2624630473","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624630473?lang=zh_cn&edition=fundamental","pubTime":"2026-04-03 13:44","pubTimestamp":1775195040,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ （来源：界面新闻）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-04-03/doc-inhteyif8908490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0175","BK0010","BK0250","BK0185","159992","BK1574","600056","BK0082","BK0188","06978","BK1161","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":12,"totalSize":241,"code":"91000000","status":"200"}]}}